About LeadInvent
LeadInvent is a company based in Exton (United States) founded in 2006 by Pankaj Sharma and Surojit Bose. It operates as a B2B. LeadInvent operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Exton, United States
- Founders Pankaj Sharma, Surojit Bose
- SectorsHealthcare
- Website leadinvent.com
- Social X
- Legal Name Leadinvent Technologies Private Limited
- Date of Incorporation 14 Nov, 2006
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹5,916
FY 2020 · -94% YoY
- Net Profit₹5,255
FY 2020 · 89% margin
- EBITDA₹5,255
FY 2020 · 89% margin
Associated legal entities of LeadInvent
LeadInvent operates through Leadinvent Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Leadinvent Technologies Private Limited CIN U72900DL2006PTC155445 | Active | 14 Nov 2006 | New Delhi, Delhi | ₹0.0 Cr | – | 3 | View details |
Board of directors of Leadinvent Technologies Private Limited (LeadInvent)
Leadinvent Technologies Private Limited is the primary company behind LeadInvent. The board of Leadinvent Technologies Private Limited currently have 3 directors; the longest-serving is Praveen Agrawal, appointed in 2006.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Praveen Agrawal DIN 01366795 | Director | 14 Nov 2006 | 19 yrs 10 mo | Leadinvent Technologies Private Limited |
| Pankaj Sharma DIN 01367191 | Director | 14 Nov 2006 | 19 yrs 10 mo | Leadinvent Technologies Private Limited |
| Surojit Bose DIN 01191048 | Director | 05 Mar 2007 | 19 yrs 7 mo | Leadinvent Technologies Private Limited |
People of LeadInvent
2 people are tracked at LeadInvent (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for LeadInvent
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of LeadInvent
Figures of Leadinvent Technologies Private Limited, the primary company behind LeadInvent, for FY 2020. Revenue was ₹5,916 (-94% year on year). Net profit was ₹5,255 (89% margin). EBITDA was ₹5,255 (89% margin). Revenue has grown at a compounded annual rate of -59% over three years and -43% over five years.
- ₹5,916Revenue · FY 2020 · -94% YoY
- ₹5,255Net profit · 89% margin
- ₹5,255EBITDA · 89% margin
- ₹2.6 LakhPaid-up capital
- -59%Revenue CAGR, 3 years
- -43%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Leadinvent Technologies Private Limited are on its company page.
Detailed financial statements for LeadInvent
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of LeadInvent
LeadInvent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | – | Therapeutics for genetic diseases are developed through targeted interventions. | |
| atai.life | 2018 | Munich, Germany | $386.67M | – | A biopharmaceutical company accelerating innovative mental health treatments. | |
| forgebiologics.com | 2020 | Columbus, United States | $250M | 118 | Gene therapies for rare diseases are developed to treat patients. | |
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. | |
| cariboubio.com | 2011 | Berkeley, United States | $156.55M | 92 | Provider of cell therapies to treat cancer and hematologic conditions | |
| kriyatherapeutics.com | 2012 | Redwood, United States | $930.93M | 159 | Developer of therapeutic solutions for the treatment of diabetes | |
| strandtx.com | 2017 | Cambridge, United States | $103.14M | 47 | mRNA therapeutics platform is provided for multi-functional treatments. | |
| editasmedicine.com | 2013 | Cambridge, United States | $210M | 257 | Therapeutics for rare genetic diseases are developed using CRISPR technology. |
Detailed competitors of LeadInvent
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to LeadInvent
10 companies that operate in the same segment as LeadInvent (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LeadInvent
LeadInvent was founded in 2006.
LeadInvent is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Pankaj Sharma is the current CEO of LeadInvent. They have also founded this company.
The primary company behind LeadInvent, Leadinvent Technologies Private Limited, reported revenue of ₹5,916 for FY 2020, down 94% year on year.
LeadInvent offers molecule simulation technology for drug discovery and computer-aided design, focusing on producing pharmaceutical products, drug discovery, simulation technology, and computer-aided design. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
LeadInvent's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
LeadInvent operates through Leadinvent Technologies Private Limited.
The legal entities of LeadInvent currently have 3 directors, including Praveen Agrawal, Pankaj Sharma, Surojit Bose.